Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Shortage reports
Actual shortage:
18 (13%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
121 (86%)
140
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
29 (100%)
Reversed:
0 (0%)
29
34 (20%)
18 (100%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-ROSUVASTATIN | 40MG | TABLET | Actual shortage | 2025-03-18 | 2025-04-11 | 252959 |
| MINT-SERTRALINE | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-09 | 35483 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35486 |
| MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95927 |
| MINT-SIMVASTATIN | 20MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95932 |
| MINT-SIMVASTATIN | 40MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95935 |
| MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35489 |
| MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95938 |
| MINT-SOLIFENACIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35492 |
| MINT-SOLIFENACIN | 10MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35495 |
| MINT-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-09-19 | 2023-03-13 | 169552 |
| MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-01-11 | 2021-04-05 | 131333 |
| MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-09-19 | 2023-03-13 | 169555 |
| MINT-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-01-29 | 2024-03-26 | 217681 |
| MINT-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-07 | 2018-01-04 | 28570 |
| MINT-TOPIRAMATE | 100MG | TABLET | Resolved | 2024-01-29 | 2024-12-05 | 217684 |
| MINT-TOPIRAMATE | 200MG | TABLET | Resolved | 2024-01-29 | 2024-12-05 | 217687 |
| MINT-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2019-10-09 | 2019-12-10 | 95944 |
| MINT-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2020-04-25 | 2024-12-05 | 113199 |
| MINT-ZOPICLONE | 5MG | TABLET | Resolved | 2020-07-13 | 2020-11-03 | 120139 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
| MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
| MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
| MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |